基可生醫股份有限公司

GEcoll Biomedical aims at the demand of high-value biological raw materials. The first pipeline recombinant human collagen can be applied to thousands fields including R&D of pharmaceuticals , medical devices and skin care products. GEcoll Biomedical also provides services of disease animal models, gene editing consulting to meet the needs from industry and academic in Asian regions. GEcoll’s recombinant human collagen is currently at the stage of mass production optimization and commercialization. We are actively seeking international strategic partners to jointly develop downstream products like dermal filler and bone graft. Combining high-value biomaterial and international channel, GEcoll wish to create a win-win situation with valuable partners.